Clinical characteristics, treatment characteristics, and endpoints assessed in real-world clinical practice of talazoparib in patients with HER2-negative BRCA-associated breast cancerAuthor:Huyvanyuk O.A. Т. 13, № 2 (50)
The choice of adjuvant treatment of endometrial cancer III A-C stagesAuthors: Dyakiv I.B. Kryzhanivska A.E. Ryzhyk V.M. Sokolovska M.V.... Т. 13, № 2 (50)
Neck lymph node metastasis from unknown primary lesionAuthors: Halay O.O. Bilynskyi B.T. Bondarenko S.G. Duda O.R.... Т. 13, № 2 (50)
